Related Experiment Videos
Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma.
Lui Shiong Lee1, Sidney K H Yip, Yeh Hong Tan
1Department of Urology, Singapore General Hospital, Singapore, Singapore.
Scandinavian Journal of Urology and Nephrology
|August 19, 2006
Summary
Hand-assisted laparoscopic nephroureterectomy (HALN) and laparoscopic nephroureterectomy (LN) are safe and effective minimally invasive treatments for upper urinary tract transitional cell carcinoma (TCC). These procedures offer favorable oncological outcomes compared to open surgery.
Area of Science:
- Urology
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Open radical nephroureterectomy is the established treatment for upper urinary tract transitional cell carcinoma (TCC).
- Laparoscopic nephroureterectomy (LN) presents a minimally invasive alternative with potential patient benefits.
Purpose of the Study:
- To evaluate the safety and efficacy of hand-assisted laparoscopic nephroureterectomy (HALN) and total LN.
- To assess perioperative and oncological outcomes of HALN and LN for upper urinary tract TCC.
Main Methods:
- Retrospective review of patients undergoing HALN or LN for localized upper urinary tract TCC (2001-2005).
- Analysis of demographic data, operative parameters, and follow-up data.
- Histological confirmation of urothelial carcinoma in all cases.
Main Results:
- 31 patients with a median age of 71 years underwent HALN or LN.
- Mean operative time was 236 minutes, mean blood loss 365 ml, with no conversions to open surgery.
- Mean hospital stay was 7 days, with clear oncological margins in 27 cases and a mean follow-up of 28 months.
Conclusions:
- HALN and LN are safe and effective alternatives to open surgery for upper urinary tract TCC.
- Medium-term follow-up indicates favorable oncological results.
- Larger studies and longer follow-up are needed to establish HALN and LN as standard treatments.